|
Jeffrey Rothschild is a partner in the law firm of McDermott Will & Emery LLP based in the Firm's New York office. He is a member of the Mergers and Acquisitions Practice Group. Although his practice focuses primarily on publicly traded mergers & acquisitions, Jeffrey also represents privately held companies in connection with mergers and acquisitions, as well as public and private companies in connection with dispositions, equity investments, public and private offerings of securities and other general corporate and securities matters. He has represented companies in a variety of industries, including telecommunications, healthcare, energy, and retail services. Jeffrey frequently represents financial advisors in M&A transactions and leads McDermott's financial advisory practice which was ranked 4th by Corporate Control Alert in terms of number of M&A transactions announced in the first half of 2007. In addition to his transactional work, he regularly advises clients in connection with general corporate issues, including fiduciary duties analysis, disclosure philosophy and compliance with Federal securities laws
Jeffrey has authored numerous articles in both The Deal magazine and in the yearly Euromoney publication.
Prior to joining McDermott, Jeffrey practiced law in New York concentrating in M&A and securities work, representing public companies, investment banks and LBO firms, and was an investment banker at J.P. Morgan Chase & Co. in the mergers & acquisitions group.Representative Experience:
Representing UCS Group, a South African company, in connection with its pending acquisition of the operating assets of AquiTec, a UK software firm.
Representing Banc of America Securities, as financial advisor to the Board of Directors of Iberdrola, S.A. in its pending $8.6 billion acquisition of Energy East Corporation
Representing Morgan Joseph & Co. Inc. as financial advisor to the board of directors of Peerless Systems Corporation in its sale of substantially all of its intellectual property and certain other assets to Kyocera Mita Corporation for approximately $37 million; and represented Morgan Joseph as financial advisor to a special committee of the board of directors of Radiation Therapy Services in its $1.1 billion sale to Vestar Capital Partners ; as financial advisor to Noble International in its $300 million strategic business combination with the laser-welded blank business of Arcelor Mittal; as financial advisor to Bio-Imaging Research, Inc. in its $21 million sale to Varian Medical Systems Inc.; as financial advisor to the audit committee of the board of directors to American Property Investors, Inc., the General Partner of American Real Estate Partners, L.P., in its $652 million acquisition of equity interests in 3 oil & gas companies and The Sands Hotel and Casino; and as financial advisor to Eagle Supply Group Inc., in its sale to Gulfside Supply, Inc.
Representing Houlihan Lokey Howard & Zukin, as financial advisor to Platinum Equity in its pending $420 million acquisition of Covad Communications, and represented Houlihan Lokey as financial advisor to the Special Committee of the Board of Directors of Accredited Home Lenders Holding Co. in its sale to Lone Star Fund V (U.S.) L.P. for a total purchase price of approximately $296 million; as financial advisor to the Special Committee of the Board of Directors of BioVeris Corporation in its $600 million sale to Roche; as financial advisor to the Special Committee of the Board of Directors of Stratagene Corporation in its $246 million sale to Agilent Technologies; and as financial advisor to the Special Committee of the Board of Directors of Trover Solutions, Inc. in its sale to an affiliate of Thomas Weisel. | 